Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1667913rdf:typepubmed:Citationlld:pubmed
pubmed-article:1667913lifeskim:mentionsumls-concept:C0003174lld:lifeskim
pubmed-article:1667913lifeskim:mentionsumls-concept:C0013982lld:lifeskim
pubmed-article:1667913lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1667913lifeskim:mentionsumls-concept:C1134558lld:lifeskim
pubmed-article:1667913pubmed:issue3lld:pubmed
pubmed-article:1667913pubmed:dateCreated1992-7-15lld:pubmed
pubmed-article:1667913pubmed:abstractTextThe possible mechanism underlying the vasorelaxant effect of emodin isolated from a Chinese herb, was investigated in this study. Emodin dose dependently relaxed isolated vascular rings of human internal mammary artery and saphenous vein, rabbit thoracic aorta, abdominal aorta and mesenteric artery, and rat thoracic aorta. There were no differences in the sensitivity (IC50) and maximal relaxation between intact and endothelium-denuded preparations of rat aorta. In the presence of emodin (10 microM), the contractile responses of rat aorta to phenylephrine, serotonin and potassium chloride were depressed. The relaxation response to acetylcholine was attenuated by emodin, whereas that to isoproterenol was unaffected. The relaxation response to emodin was inhibited by free radical scavengers, superoxide dismutase, catalase and mannitol, and guanylate cyclase inhibitors, methylene blue and hemoglobin. Catalase was the most effective scavenger. Quinacrine (phospholipase A2 inhibitor), indomethacin (cyclooxygenase inhibitor) and nordihydroguaiaretic acid (NDGA, lipoxygenase inhibitor) potentiated the relaxation induced by emodin. NDGA was the most effective potentiator. Exposure of aortic rings to emodin (10 microM) increased the basal level of guanosine 3',5'-cyclic monophosphate (cGMP). It is suggested that the vasorelaxant effect of emodin may be mainly due to cGMP accumulation as a result of guanylate cyclase activation by free radicals and/or hydrogen peroxide generated from semiquinone.lld:pubmed
pubmed-article:1667913pubmed:languageenglld:pubmed
pubmed-article:1667913pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1667913pubmed:citationSubsetIMlld:pubmed
pubmed-article:1667913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1667913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1667913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1667913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1667913pubmed:statusMEDLINElld:pubmed
pubmed-article:1667913pubmed:monthDeclld:pubmed
pubmed-article:1667913pubmed:issn0014-2999lld:pubmed
pubmed-article:1667913pubmed:authorpubmed-author:ChuS HSHlld:pubmed
pubmed-article:1667913pubmed:authorpubmed-author:ChenC CCClld:pubmed
pubmed-article:1667913pubmed:authorpubmed-author:LeeC RCRlld:pubmed
pubmed-article:1667913pubmed:authorpubmed-author:HuangH CHClld:pubmed
pubmed-article:1667913pubmed:authorpubmed-author:ChaoP DPDlld:pubmed
pubmed-article:1667913pubmed:issnTypePrintlld:pubmed
pubmed-article:1667913pubmed:day3lld:pubmed
pubmed-article:1667913pubmed:volume205lld:pubmed
pubmed-article:1667913pubmed:ownerNLMlld:pubmed
pubmed-article:1667913pubmed:authorsCompleteYlld:pubmed
pubmed-article:1667913pubmed:pagination289-94lld:pubmed
pubmed-article:1667913pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1667913pubmed:meshHeadingpubmed-meshheading:1667913-...lld:pubmed
pubmed-article:1667913pubmed:meshHeadingpubmed-meshheading:1667913-...lld:pubmed
pubmed-article:1667913pubmed:meshHeadingpubmed-meshheading:1667913-...lld:pubmed
pubmed-article:1667913pubmed:meshHeadingpubmed-meshheading:1667913-...lld:pubmed
pubmed-article:1667913pubmed:meshHeadingpubmed-meshheading:1667913-...lld:pubmed
pubmed-article:1667913pubmed:meshHeadingpubmed-meshheading:1667913-...lld:pubmed
pubmed-article:1667913pubmed:meshHeadingpubmed-meshheading:1667913-...lld:pubmed
pubmed-article:1667913pubmed:meshHeadingpubmed-meshheading:1667913-...lld:pubmed
pubmed-article:1667913pubmed:meshHeadingpubmed-meshheading:1667913-...lld:pubmed
pubmed-article:1667913pubmed:meshHeadingpubmed-meshheading:1667913-...lld:pubmed
pubmed-article:1667913pubmed:meshHeadingpubmed-meshheading:1667913-...lld:pubmed
pubmed-article:1667913pubmed:meshHeadingpubmed-meshheading:1667913-...lld:pubmed
pubmed-article:1667913pubmed:meshHeadingpubmed-meshheading:1667913-...lld:pubmed
pubmed-article:1667913pubmed:meshHeadingpubmed-meshheading:1667913-...lld:pubmed
pubmed-article:1667913pubmed:year1991lld:pubmed
pubmed-article:1667913pubmed:articleTitleVasorelaxant effect of emodin, an anthraquinone from a Chinese herb.lld:pubmed
pubmed-article:1667913pubmed:affiliationDepartment of Pharmacology, College of Medicine, National Taiwan University, Taipei, R.O.C.lld:pubmed
pubmed-article:1667913pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1667913pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:1667913pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed